Absolutely. This will be achieved with a 50% deat
Post# of 146837
Even achieving a good p-value (slightly greater than, say 0.005) the FDA (if given the data from Board) might conclude that the power is not good enough. However, under the circumstances, the information of "drug goodness" is very valuable to us investors, and, by reflection to the SP .
One can wait calmly expecting the predictable outcome